Related Experiment Videos
[Atopic dermatitis and cathepsin E].
Takayuki Tsukuba1, Kenji Yamamoto
1Department of Pharmacology, Graduate School of Dental Science, Kyushu University, Fukuoka, Japan. tsukuba@dent.kyushu-u.ac.jp
Summary
Cathepsin E deficiency in mice triggers atopic dermatitis (AD)-like skin conditions by increasing inflammatory cytokines. This discovery offers a new model for studying human AD pathogenesis.
Area of Science:
- Biochemistry
- Immunology
- Dermatology
Context:
- Cathepsin E is an aspartic proteinase primarily found in immune cells and skin.
- Atopic dermatitis (AD) is a chronic inflammatory skin condition with complex etiology.
- Previous research has not fully elucidated the role of Cathepsin E in AD development.
Purpose:
- To investigate the role of Cathepsin E in the development of atopic dermatitis.
- To establish a novel animal model for studying human AD.
- To explore the mechanisms linking Cathepsin E deficiency to AD-associated phenotypes.
Summary:
- Cathepsin E-deficient mice spontaneously developed AD-like skin lesions under conventional, but not SPF, conditions.
- These mice exhibited key AD phenotypes: eosinophilia, elevated IgE, IL-18, IL-1beta, and Th2 cytokine production.
- Deficiency led to impaired degradation of IL-18 and IL-1beta, suggesting cytokine accumulation as a pathogenic mechanism.
- Reduced Cathepsin E levels were observed in human AD patients and a mouse AD model.
Impact:
- Identifies Cathepsin E deficiency as a strong inducer of AD in both mice and humans.
- Highlights the accumulation of IL-18 and IL-1beta as a key factor in AD pathogenesis.
- Establishes cathepsin E-deficient mice as a valuable new model for AD research.
- Provides insights into the immunological pathways underlying atopic dermatitis.